XTLB - xtlbio.com Stock Quotes
The current financial health of XTL Biopharmaceuticals (XTLB) relies on remaining capital, as a stable cash flow is absent due to asset restructuring. Risks are minimized by a broad spectrum of research in oncology and autoimmune pathologies, where the indicator stands at 1.59. The share price retrospective demonstrates the dynamics of a business creating a comprehensive environment for systemic lupus erythematosus therapy and the implementation of new medical standards.
XTL Biopharmaceuticals Ltd - analytical breakdowns and key metrics (XTLB)
- current price and projected stock value:
- market capitalization statistics:
- issuer book value statistics:
- debt and solvency information:
Debt to Equity XTL Biopharmaceuticals|XTLB - Long-Term Liabilities to Equity|Short-Term Debt to Capital XTL Biopharmaceuticals, Ltd.|XTLB - Aggregate Debt Obligations|Debts to Book Capitalization XTL Biopharmaceuticals Ltd|XTLB - Company Long-Term Debts|Company Short-Term Debt XTL Biopharmaceuticals|Quick Liquidity xtlbio.com
- company profitability and valuation multiples indicators:
XTLB - Net Income|Projected Future Earnings XTL Biopharmaceuticals|XTLB - P/E Multiple|Projected Price to Earnings XTL Biopharmaceuticals Ltd.|XTLB - Growth-Adjusted Payback Ratio|EV/EBITDA Multiple XTL Biopharmaceuticals Ltd|XTLB - Operating income before deduction of amortization|Earnings per share for the last twelve months XTL Biopharmaceuticals|XTLB - Net earnings per share for the last 12 months|Year-over-year earnings per share growth for the last twelve months xtlbio.com|XTLB - Net earnings per share growth this year|Expected earnings per share growth for next year XTL Biopharmaceuticals
- issuer revenue and sales details:
Fundamental valuation:XTL Biopharmaceuticals
The potential of XTL Biopharmaceuticals (XTLB) in treating orphan diseases makes its share price a derivative of clinical trial success and external funding volumes. Analyzing this price chart, investors assess market capitalization through daily closing quotes, where current levels reflect the market's discounted expectations regarding future drug commercialization and the overall investment attractiveness of the business.
Analysis of competing companies
Stock Quotes ARGX (argenx SE)|biontech.de - Share Price|Abivax - Stock Quotes|Price ADMA (ADMA Biologics Inc)|PTGX - Price Chart|IMVT: Price Chart|KNSA: Stock Price|GRFS (grifols.com) - Price Chart|Price Chart Adaptive Biotechnologies Corporation|Celldex Therapeutics Inc - Quote Chart|Stock Price AUPH|BCRX (BioCryst Corp) - Price Performance Chart|Stock Price VERA (Vera Therapeutics, Inc.)|Stock Price dianthustx.com DNTH|PHVS - Price Chart|Price Performance Chart ABCL (abcellera.com)|Tourmaline Corp (TRML) - Price Chart|Stock Quotes Precigen Corp|PHAR (Pharming Group N.V.) - Stock Price|Stock Price nektar.com|Stock Quotes UPB (Upstream Bio)|ZBIO (Zenas Bio) - Price Performance Chart|Stock Price IMNM (Immunome Corp)|Market Chart Gossamer Bio Corp. (GOSS)|KALV - Price Chart|septerna.com (SEPN) - Stock Quotes|Pieris Pharmaceuticals, Inc. (PVLA) - Price Chart|Stock Quotes Savara Inc|Stock Quotes RIGL|Stock Price AnaptysBio Inc.|Price Chart Astria Therapeutics (ATXS)|engene.com - Share Price|Stock Price RAPT (RAPT Therapeutics, Inc.)|Aerovate Therapeutics, Inc. (JBIO) - Market Price|ACRS: Stock Quotes|KYTX (Kyverna Therapeutics, Inc) - Share Price|TLSA (Tiziana Life Sciences) - Stock Quotes|CABA: Price|Price Chart Ventyx Biosciences, Inc.|Price Chart THTX|Stock Quotes AVTX (Avalo Therapeutics Inc.)|ELDN (Eledon Pharmaceuticals, Inc) - Price Performance Chart|Stock Price AGEN (Agenus)|climbbio.com - Price Chart|Zura Bio Limited - Stock Price|Market Chart aTyr Pharma Inc ATYR|adagene.com (ADAG) - Price Chart|Market Price Ikena Oncology (IMA)|Price Chart Shattuck Labs Inc|Equillium Bio - Quote Chart|Stock Price CNTB|IMUX (immunic-therapeutics.com) - Price Performance Chart|Stock Price ATRA (Atara Bio)|Stock Price InflaRx NV IFRX|XFOR - Price Chart|Price Performance Chart ACET (Adicet Bio)|celularity.com (CELU) - Price Chart|Stock Quotes INmune Bio Inc|BRNS (Barinthus Bio) - Stock Price|Stock Price Kezar Life Sciences Inc|Stock Price SABS|Stock Quotes akaritx.com AKTX|Stock Price ENLV (Enlivex Therapeutics Ltd.)|Q32 Bio Inc (QTTB) - Market Price|GOVX: Stock Quotes|EDSA - Stock Price|IBIO (iBio, Inc.) - Stock Quotes|CARM: Price|BOLT (Bolt Biotherapeutics Inc.) - Stock Price|HCW Biologics Inc (HCWB) - Market Chart|Stock Price APVO|Stock Quotes AIM ImmunoTech, Inc. AIM|Stock Price ADTX (Aditxt, Inc.)|Stock Price gribio.com GRI|XRTX - Price Chart|HIND: Price Chart|Revelation Bio (REVB) - Price Chart|INDP - Market Chart|Stock Quotes SCNI|Share Price CALI (CalciMedica Corp)|Stock Quotes AFMD (Affimed)|Price ALLK|Price Chart HOOKIPA Pharma HOOK|IGM Biosciences Inc. - Price Chart|iTeos Therapeutics - Stock Price|OCEA: Price Chart|TC BioPharm (TCBP) - Price Chart|Quote Chart THRD (Third Harmonic Bio Inc.)
